
3 Questions Decision-Makers Raise About FDA Regulatory and Compliance: Premarket approval timelines, post-market adverse event reporting, and warning label adequacy.In-house counsel and compliance officers managing FDA regulatory and compliance obligations face a landscape where regulatory expectations shift faster than many organizations can adapt. The Food and Drug Administration oversees products ranging from pharmaceuticals and medical devices to dietary supplements and cosmetics, each with distinct compliance pathways and enforcement priorities. A single misstep in premarket submissions, labeling, or adverse event reporting can trigger warning letters, consent decrees, or product seizures. This article examines the legal risks that most frequently trigger enforcement action and the strategic decisions that should inform your compliance posture now.
阅读更多

3 Practical Points on Memorandum of Understanding from Counsel: Non-binding intent, binding dispute exposure, enforceability turns on language.A memorandum of understanding serves as a preliminary agreement between parties to outline shared intentions before executing a formal contract. For in-house counsel and business decision-makers, the central challenge is determining when an MOU creates legal obligations despite its purported non-binding status, and what risks arise if parties later dispute the document's enforceability. Courts frequently examine the parties' language, conduct, and context to decide whether an MOU is truly preliminary or whether it constitutes a binding agreement. Understanding this distinction is critical because litigation often hinges on how a court interprets the document's actual legal effect, not merely its label.
阅读更多

3 Bottom-Line Points on Compliance Management from Counsel: Regulatory deadlines create enforcement exposure, internal audits reveal gaps before regulators do, documentation standards vary by industryCompliance management in a modern business environment requires more than reactive problem-solving. Organizations face overlapping regulatory frameworks, evolving enforcement priorities, and substantial penalties for lapses. The stakes are real: a single missed deadline or inadequate control can trigger investigations, fines, reputational damage, and operational disruption. This article addresses the strategic decisions in-house counsel and business decision-makers should evaluate now to build defensible compliance infrastructure and reduce legal risk.
阅读更多

3 Questions Decision-Makers Raise About Top M&A Law Firm Matters: Due diligence scope and timeline, representation and indemnification exposure, regulatory clearance delays.Mergers and acquisitions involve intricate legal, financial, and operational complexities that demand strategic foresight from decision-makers. Whether you are an in-house counsel, a business owner, or a transaction manager, understanding the critical legal risks in top M&A law firm engagements shapes how you navigate deal structure, manage vendor relationships, and allocate resources. The stakes are high: a missed regulatory filing, an inadequate indemnification clause, or a poorly scoped due diligence process can unwind months of negotiation and expose your organization to unforeseen liability.
阅读更多

A business expert witness analyzes financial records, calculates damages, and testifies on business value in New York litigation. In a commercial dispute, a business expert witness can decide whether a judge or jury accepts your damages theory. Parties that retain an expert late often face tighter disclosure schedules under CPLR 3101(d), which leaves less time to prepare and respond to challenges. This guide covers what these witnesses do, how courts test their methods, and what makes an opinion survive cross-examination.
阅读更多

3 Questions Decision-Makers Raise About Exclusive Sales Contracts: Territorial scope and duration limits, non-compete enforceability, termination and damages exposure.An exclusive sales contract grants one party the sole right to sell or distribute a product or service within a defined territory or customer base for a specified period. From a practitioner's perspective, these agreements create significant legal exposure because the parties often hold conflicting expectations about what exclusive actually means in practice, and disputes over performance, territory definition, and early termination can escalate quickly into costly litigation. Decision-makers should understand that exclusive sales contracts are heavily regulated under antitrust law, state contract law, and the Uniform Commercial Code, and that courts interpret these agreements with particular scrutiny when they restrict competition or market access.
阅读更多
